ANDROGEN DEPRIVATION THERAPY
Clinical trials for ANDROGEN DEPRIVATION THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANDROGEN DEPRIVATION THERAPY trials appear
Sign up with your email to follow new studies for ANDROGEN DEPRIVATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to halt prostate cancer spread with targeted radiation
Disease control Recruiting nowThis Phase 3 trial is testing whether adding pelvic radiotherapy to standard hormone therapy can delay cancer progression in men whose prostate cancer has spread to nearby lymph nodes after prostate removal surgery. About 372 participants will be randomly assigned to receive eith…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill combo aims to boost prostate cancer cure rates
Disease control Recruiting nowThis early-phase trial is testing whether taking two hormone-blocking pills—relugolix and enzalutamide—before and after standard radiation or surgery can help cure high-risk locally advanced prostate cancer. About 46 men will participate to first find a safe dose, then see if the…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Exercise program aims to protect hearts of black men on prostate cancer treatment
Disease control Recruiting nowThis study tests whether a 16-week, culturally tailored exercise program (aerobic and resistance training) can lower heart disease risk in Black men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). The study will enroll 62 participants, who w…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (androgen deprivation therapy). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a menopause drug cool hot flashes in men with prostate cancer?
Symptom relief Recruiting nowThis study tests a drug called fezolinetant, already approved for hot flashes in menopausal women, to see if it can reduce hot flashes in men with prostate cancer who are on hormone-lowering therapy. About 32 men will take the drug daily for 28 days. The goal is to measure how mu…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Acupuncture may cool hot flashes in men on prostate cancer hormone therapy
Symptom relief Recruiting nowThis study tests whether acupuncture can reduce hot flashes and improve quality of life in men receiving hormone therapy for prostate cancer. Twenty-four men will be randomly assigned to start acupuncture right away or after a delay, and all will receive standard lifestyle advice…
Matched conditions: ANDROGEN DEPRIVATION THERAPY
Phase: NA • Sponsor: Inova Health Care Services • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC